These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4560973)
21. [Parkinsonism and levodopa: apropos of 300 patients followed for 2 years]. Petit H; Chevalier-Lefebvre J; Warot P Lille Med; 1973 Mar; 18(3):258-67. PubMed ID: 4727492 [No Abstract] [Full Text] [Related]
22. [Effects of L-dopa and stereotaxic surgery in Parkinsonism]. Sugita K; Mutsuga N; Takaoka Y; Takeda A No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927 [No Abstract] [Full Text] [Related]
23. [Levodopa treatment in parkinsonism]. Rinne UK; Sonninen V; Siirtola T Duodecim; 1971; 87(12):933-47. PubMed ID: 5088232 [No Abstract] [Full Text] [Related]
24. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa]. Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429 [No Abstract] [Full Text] [Related]
26. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor]. Stammler A; Vielhaber K Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct; 40(10):564-8. PubMed ID: 4565521 [No Abstract] [Full Text] [Related]
27. Effectiveness and limitations of long-term levodopa therapy in Parkinsonism. Celesia GG; Barr AN Wis Med J; 1970 Oct; 69(10):227-9. PubMed ID: 5472626 [No Abstract] [Full Text] [Related]
28. Improvement in mono-manual dexterity in parkinsonism when supplementing levodopa with an extracerebral decarboxylase inhibitor, RO 4-4602. Knutsson E; Mårtensson A Scand J Rehabil Med; 1974; 6(2):89-93. PubMed ID: 4837060 [No Abstract] [Full Text] [Related]
29. Treatment of parkinsonism by amantadine and levodopa. Mawdsley C; Williams IR; Pullar IA; Davidson DL; Kinloch NE Clin Pharmacol Ther; 1972; 13(4):575-83. PubMed ID: 4557584 [No Abstract] [Full Text] [Related]
31. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method]. Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721 [No Abstract] [Full Text] [Related]
32. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines]. Uono M; Tanabe H; Yano Y; Nakao K No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082 [No Abstract] [Full Text] [Related]
33. L-dopa and amantadine in the therapy of parkinsonism. Weeth JB; Shealy CN; Mercier DA Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055 [No Abstract] [Full Text] [Related]
34. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism. Peterson CR; Calvert JC; Canzoneri J; Leavitt LA; McCutchen JJ; Schwartz L Am J Phys Med; 1972 Aug; 51(4):171-81. PubMed ID: 5052844 [No Abstract] [Full Text] [Related]
35. The influence of a previous thalamotomy on the L-dopa effects on mono-manual dexterity in parkinsonism. Knutsson E; Mårtensson A; Meyerson BA; Risberg AM Scand J Rehabil Med; 1973; 5(3):130-3. PubMed ID: 4754551 [No Abstract] [Full Text] [Related]
36. Levodopa and parkinsonism. Robinson MB Am J Nurs; 1974 Apr; 74(4):656-61. PubMed ID: 4493649 [No Abstract] [Full Text] [Related]
37. The Eaton collaborative study of levodopa therapy in parkinsonism: a summary. Keenan RE Neurology; 1970 Dec; 20(12):Suppl:46-65. PubMed ID: 5529915 [No Abstract] [Full Text] [Related]
38. Synergism of levodopa by alpha methyldopa. Fermaglich J; O'Doherty DS Trans Am Neurol Assoc; 1971; 96():231-4. PubMed ID: 5159089 [No Abstract] [Full Text] [Related]
39. Aromatic amino acids and modification of parkinsonism. Cotzias GC; Van Woert MH; Schiffer LM N Engl J Med; 1967 Feb; 276(7):374-9. PubMed ID: 5334614 [No Abstract] [Full Text] [Related]
40. Pyridoxine, DOPA, and Parkinsonism. Yahr MD; Duvoisin RC; Côté L; Cohen G Adv Biochem Psychopharmacol; 1972; 4():185-94. PubMed ID: 4555927 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]